SABS - SAB Biotherapeutics, Inc.
IEX Last Trade
3.66
-0.180 -4.918%
Share volume: 57,960
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$3.84
-0.18
-0.05%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-15 | 2023-08-21 | 2023-11-13 | 2024-03-29 | 2024-05-20 | 2024-08-08 | 2024-11-06 | |
| Total revenue | 581.101 K | 85.518 K | 1.267 M | 305.011 K | 944.575 K | 263.137 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 581.101 K | 85.518 K | 1.267 M | 305.011 K | 944.575 K | 263.137 K | 0.000 | |
| -85.28% | 1,381.98% | -75.93% | 209.69% | -72.14% | -100.00% | |||
| Operating expenses | 7.983 M | 6.562 M | 6.590 M | 19.179 M | 12.335 M | 10.465 M | 11.309 M | |
| Selling general and admin | 3.447 M | 2.900 M | 2.571 M | 14.881 M | 4.189 M | 3.643 M | 3.479 M | |
| Research and development | 4.536 M | 3.662 M | 4.020 M | 4.297 M | 8.146 M | 6.822 M | 7.831 M | |
| Total expenses | 7.983 M | 6.562 M | 6.590 M | 19.179 M | 12.335 M | 10.465 M | 11.309 M | |
| -17.80% | 0.43% | 191.02% | -35.68% | -15.16% | 8.07% | |||
| Operating income | -7.402 M | -6.477 M | -5.323 M | -18.874 M | -11.391 M | -10.202 M | -11.309 M | |
| Ebit | -7.402 M | -6.477 M | -5.323 M | -18.874 M | -11.391 M | -7.617 M | -10.549 M | |
| Pretax income | -7.354 M | -6.881 M | -5.102 M | -22.857 M | -5.026 M | -7.335 M | -10.349 M | |
| -6.43% | -25.85% | 347.97% | -78.01% | 45.96% | 41.09% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -7.354 M | -6.881 M | -5.102 M | -22.857 M | -5.026 M | 0.000 | 0.000 | |
| 6.43% | 25.85% | -347.97% | 78.01% | 100.00% | ||||
| Net income | -7.354 M | -6.881 M | -5.102 M | -22.857 M | -5.026 M | -7.335 M | -10.349 M | |
| 6.43% | 25.85% | -347.97% | 78.01% | -45.96% | -41.09% |